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Compendium of Animal Rabies Prevention and Control, 2008*
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Rabies is a fatal viral zoonosis and a serious public health problem (1). The disease is an acute, progressive encephalitis caused
by a lyssavirus. Although the United States has been declared free of canine rabies virus variant transmission, multiple viral variants
are maintained in wild mammal populations, and there is always a risk of reintroduction of canine rabies (2). All mammals are
believed to be susceptible to the disease, and for purposes of this document, use of the term “animal” refers to mammals.
The recommendations in this compendium serve as a basis for animal rabies-prevention and -control programs throughout
the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective
national rabies-control program. This document is reviewed annually and revised as necessary. The most current version
replaces all previous versions. These recommendations do not supersede state and local laws or requirements. Principles of
rabies-prevention and -control are detailed in Part I; recommendations for parenteral vaccination procedures are presented in
Part II; and all animal rabies vaccines licensed by the U. S. Department of Agriculture (USDA) and marketed in the United
States are listed in Part III.
Part I: Rabies Prevention and Control
A. Principles of Rabies Prevention and Control
1. Rabies Exposure. Rabies is transmitted only when the
virus is introduced into bite wounds, open cuts in
skin, or onto mucous membranes from saliva or
other potentially infectious material such as neural
tissue (3). Questions regarding possible exposures
should be directed promptly to state or local public
health authorities.
2. Public Health Education. Essential components of
rabies prevention and control include ongoing public
education, responsible pet ownership, routine veteri-
nary care, and professional continuing education. The
majority of animal and human exposures to rabies
can be prevented by raising awareness concerning:
rabies transmission routes, avoiding contact with
wildlife, and following appropriate veterinary care.
Prompt recognition and reporting of possible
exposures to medical professionals and local pub-
lic health authorities is critical.
3. Human Rabies Prevention. Rabies in humans can
be prevented either by eliminating exposures to
rabid animals or by providing exposed persons with
prompt local treatment of wounds combined with
the administration of human rabies immune globu-
lin and vaccine. The rationale for recommending
preexposure and postexposure rabies prophylaxis and
details of their administration can be found in the
current recommendations of the Advisory Commit-
tee on Immunization Practices (ACIP) (3). These rec-
ommendations, along with information concerning
the current local and regional epidemiology of ani-
mal rabies and the availability of human rabies
biologics, are available from state health departments.
4. Domestic Animals. Local governments should initiate
and maintain effective programs to ensure vaccination
of all dogs, cats, and ferrets and to remove strays and
unwanted animals. Such procedures in the United
States have reduced laboratory-confirmed cases of
rabies in dogs from 6,949 in 1947 to 71 in 2006 (2).
Because more rabies cases are reported annually
involving cats (247 in 2006) than dogs, vaccination of
cats should be required (2). Animal shelters and animal-
control authorities should establish policies to ensure
that adopted animals are vaccinated against rabies. The
recommended vaccination procedures and the licensed
animal vaccines are specified in Parts II and III of this
compendium, respectively.
5. Rabies in Vaccinated Animals. Rabies is rare in vac-
cinated animals (4). If such an event is suspected, it
should be reported to state public health officials; the
vaccine manufacturer; and USDA, Animal and Plant
Health Inspection Service, Center for Veterinary
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Biologics (Internet: http://www.aphis.usda.gov/animal_
health/vet_biologics/vb_adverse_event.shtml; telephone:
800-752-6255; or e-mail: CVB@usda.gov). The labo-
ratory diagnosis should be confirmed and the virus
variant should be characterized by a rabies reference
laboratory. A thorough epidemiologic investigation
should be conducted.
6. Rabies in Wildlife. The control of rabies among wild-
life reservoirs is difficult (5). Vaccination of free-
ranging wildlife or selective population reduction
might be useful in some situations, but the success of
such procedures depends on the circumstances sur-
rounding each rabies outbreak (see Part I. C.). Because
of the risk of rabies in wild animals (especially rac-
coons, skunks, coyotes, foxes, and bats), the AVMA,
CSTE, NACA, and NASPHV strongly recommend
the enactment and enforcement of state laws prohib-
iting their importation, distribution, translocation, and
private ownership.
7. Rabies Surveillance. Laboratory-based rabies surveil-
lance and variant typing are essential components of
rabies-prevention and -control programs. Accurate and
timely information is necessary to guide human
postexposure prophylaxis decisions, determine the
management of potentially exposed animals, aid in
emerging pathogen discovery, describe the epidemiol-
ogy of the disease, and assess the need for and effec-
tiveness of vaccination programs for wildlife.
8. Rabies Diagnosis. Rabies testing should be performed
in accordance with the established national standard-
ized protocol for rabies testing (http://www.cdc.gov/
rabies/docs/standard_dfa_protocol_rabies.pdf ) by a
qualified laboratory that has been designated by the
local or state health department (6,7). Euthanasia (8)
should be accomplished in such a way as to maintain
the integrity of the brain so that the laboratory can
recognize the anatomical parts. Except in the case of
very small animals, such as bats, only the head or brain
(including brain stem) should be submitted to the labo-
ratory. To facilitate laboratory processing and prevent
a delay in testing, any animal or animal specimen
being submitted for testing should preferably be stored
and shipped under refrigeration and not be frozen.
Chemical fixation of tissues should be avoided to pre-
vent significant testing delays and because it might
preclude reliable testing. Questions about testing of
fixed tissues should be directed to the local rabies
laboratory or public health department.
9. Rabies Serology. Some “rabies-free” jurisdictions
might require evidence of vaccination and rabies virus
antibodies for animal importation purposes. Rabies
virus antibody titers are indicative of a response to vac-
cine or infection. Titers do not directly correlate with
protection because other immunologic factors also play
a role in preventing rabies, and our abilities to mea-
sure and interpret those other factors are not well-
developed. Therefore, evidence of circulating rabies
virus antibodies should not be used as a substitute for
current vaccination in managing rabies exposures or
determining the need for booster vaccinations in
animals (9–11).
10. Rabies Research. Information derived from well-
designed studies is essential for the development of
science-based recommendations. Data are needed in
several areas, including viral shedding periods for live-
stock and lagomorphs, potential shedding of virus in
milk, earliest age at which rabies vaccination is effec-
tive, postexposure prophylaxis for domestic animals,
extra label vaccine use in domestic animals and wild-
life rabies reservoirs, and the ecology of wildlife rabies
reservoir species, especially in relation to the use of
oral rabies vaccines.
B. Prevention and Control Methods in Domestic and
Confined Animals.
1. Preexposure Vaccination and Management. Parenteral
animal rabies vaccines should be administered only by
or under the direct supervision of a veterinarian.
Rabies vaccinations may also be administered under the
supervision of a veterinarian to animals held in animal-
control shelters before release. Any veterinarian signing
a rabies certificate must ensure that the person admin-
istering vaccine is identified on the certificate and is
appropriately trained in vaccine storage, handling,
administration, and in the management of adverse
events. This practice assures that a qualified and respon-
sible person can be held accountable for properly vacci-
nating the animal.
Within 28 days after initial vaccination, a peak
rabies virus antibody titer is reached, and the animal
can be considered immunized (12). An animal is cur-
rently vaccinated and is considered immunized if the
initial vaccination was administered at least 28 days pre-
viously or booster vaccinations have been administered
in accordance with this compendium.
Regardless of the age of the animal at initial vaccina-
tion, a booster vaccination should be administered 1
year later (see Parts II and III for vaccines and proce-
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dures). No laboratory or epidemiologic data exist to
support the annual or biennial administration of 3- or
4-year vaccines after the initial series. Because a rapid
anamnestic response is expected, an animal is consid-
ered currently vaccinated immediately after a booster
vaccination (13).
a. Dogs, Cats, and Ferrets. All dogs, cats, and ferrets
should be vaccinated against rabies and revaccinated
in accordance with Part III of this compendium. If a
previously vaccinated animal is overdue for a booster,
it should be revaccinated. Immediately after the
booster, the animal is considered currently vaccinated
and should be placed on a schedule, depending on
the labeled duration of the vaccine used.
b. Livestock. Consideration should be given to vacci-
nating livestock that are particularly valuable. Ani-
mals that have frequent contact with humans (e.g.,
in petting zoos, fairs, and other public exhibitions)
and horses traveling interstate should be currently
vaccinated against rabies (14,15).
c. Confined Animals.
1.) Wild. No parenteral rabies vaccines are licensed
for use in wild animals or hybrids (the offspring
of wild animals crossbred to domestic animals).
Wild animals or hybrids should not be kept as
pets (16–19).
2.) Maintained in Exhibits and in Zoological
Parks. Captive mammals that are not completely
excluded from all contact with rabies vectors can
become infected. Moreover, wild animals might
be incubating rabies when initially captured;
therefore, wild-caught animals susceptible to
rabies should be quarantined for a minimum of
6 months. Employees who work with animals at
such facilities should receive preexposure rabies
vaccination. The use of pre- or postexposure
rabies vaccinations for handlers who work with
animals at such facilities might reduce the need
for euthanasia of captive animals that expose han-
dlers. Carnivores and bats should be housed in a
manner that precludes direct contact with the
public (14).
2. Stray Animals. Stray dogs, cats, and ferrets should be
removed from the community. Local health departments
and animal-control officials can enforce the removal of
strays more effectively if owned animals have identifi-
cation and are confined or kept on leash. Strays should
be impounded for at least 3 business days to determine
if human exposure has occurred and to give owners
sufficient time to reclaim animals.
3. Importation and Interstate Movement of Animals.
a. International. CDC regulates the importation of
dogs and cats into the United States. Importers of
dogs must comply with rabies vaccination require-
ments (42 CFR, Part 71.51[c] [http://www.cdc.gov/
ncidod/dq/animal.htm]) and complete CDC form
75.37 (http://www.cdc.gov/ncidod/dq/pdf/animal/
dog_quarantine_notice_08-04-06-cdc7537.pdf ).
The appropriate health official of the state of desti-
nation should be notified within 72 hours of the
arrival of any imported dog required to be placed in
confinement under the CDC regulation. Failure of
the owner to comply with these confinement require-
ments should be promptly reported to the Division of
Global Migration and Quarantine, CDC (telephone:
404-639-3441).
Federal regulations alone are insufficient to pre-
vent the introduction of rabid animals into the United
States (20,21). All imported dogs and cats are sub-
ject to state and local laws governing rabies and should
be currently vaccinated against rabies in accordance
with this compendium. Failure of the owner to
comply with state or local requirements should be
referred to the appropriate state or local official.
b. Interstate. Before interstate movement (including
commonwealths and territories), dogs, cats, ferrets,
and horses should be currently vaccinated against
rabies in accordance with this compendium’s recom-
mendations (see Part I. B.1.). Animals in transit
should be accompanied by a currently valid NASPHV
Form 51, Rabies Vaccination Certificate (http://www.
nasphv.org/Documents/RabiesVacCert.pdf ). When
an interstate health certificate or certificate of veteri-
nary inspection is required, it should contain the same
rabies vaccination information as Form 51.
c. Areas with Dog-to-Dog Rabies Transmission.
Canine rabies virus variants have been eliminated in
the United States (2). Rabid dogs have been intro-
duced into the continental United States from areas
with dog-to-dog rabies transmission (20,21). This
practice poses the risk of introducing canine-
transmitted rabies to areas where it does not currently
exist. The movement of dogs for the purposes of
adoption or sale from areas with dog-to-dog rabies
transmission should be prohibited.
4. Adjunct Procedures. Methods or procedures that
enhance rabies control include the following:
a. Identification. Dogs, cats, and ferrets should be iden-
tified (e.g., metal or plastic tags or microchips) to
allow for verification of rabies vaccination status.
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b. Licensure. Registration or licensure of all dogs, cats,
and ferrets is an integral component of an effective
rabies-control program. A fee is frequently charged
for such licensure, and revenues collected are used to
maintain rabies- or animal-control activities. Evi-
dence of current vaccination should be an essential
prerequisite to licensure.
c. Canvassing. House-to-house canvassing by animal-
control officials facilitates enforcement of vaccina-
tion and licensure requirements.
d. Citations. Citations are legal summonses issued to
owners for violations, including the failure to vacci-
nate or license their animals. The authority for offic-
ers to issue citations should be an integral part of
each animal-control program.
e. Animal Control. All local jurisdictions should
incorporate stray animal control, leash laws, animal
bite prevention, and training of personnel in their
programs.
f. Public Education. All local jurisdictions should
incorporate education covering responsible pet own-
ership, bite prevention, and appropriate veterinary
care in their programs.
5. Postexposure Management. This section refers to any
animal exposed (see Part I.A.1.) to a confirmed or sus-
pected rabid animal. Wild mammalian carnivores or
bats that are not available or suitable for testing should
be regarded as rabid animals.
a. Dogs, Cats, and Ferrets. Unvaccinated dogs, cats,
and ferrets exposed to a rabid animal should be
euthanized immediately. If the owner is unwilling to
have this done, the animal should be placed in strict
isolation for 6 months. Isolation in this context
refers to confinement in an enclosure that precludes
direct contact with people and other animals. Rabies
vaccine should be administered upon entry into iso-
lation or 1 month before release to comply with
preexposure vaccination recommendations (see Part
I.B.1.a.). There are currently no USDA licensed
biologics for postexposure prophylaxis of previously
unvaccinated domestic animals, and there is evidence
that the use of vaccine alone will not reliably prevent
the disease in these animals (22). Animals overdue
for a booster vaccination need to be evaluated on a
case-by-case basis (e.g., severity of exposure, time
elapsed since last vaccination, number of previous
vaccinations, current health status, and local rabies
epidemiology). Dogs, cats, and ferrets that are cur-
rently vaccinated should be revaccinated immediately,
kept under the owner’s control, and observed for
45 days. Any illness in an isolated or confined ani-
mal should be reported immediately to the local
health department. If signs suggestive of rabies
develop, the animal should be euthanized and the
head shipped for testing as described in Part I.A.8.
b. Livestock. All species of livestock are susceptible to
rabies; cattle and horses are the most frequently
reported infected species (2). Livestock exposed to a
rabid animal and currently vaccinated with a vac-
cine approved by USDA for that species should be
revaccinated immediately and observed for 45 days.
Unvaccinated livestock should be euthanized imme-
diately. If the animal is not euthanized it should be
kept under close observation for 6 months. Any
illness in an animal under observation should be
reported immediately to the local health department.
If signs suggestive of rabies develop, the animal should
be euthanized and the head shipped for testing as
described in Part I.A.8.
Handling and consumption of tissues from
exposed animals might carry a risk for rabies trans-
mission. Risk factors depend in part on the site(s) of
exposure, amount of virus present, severity of
wounds, and whether sufficient contaminated tissue
has been excised. If an exposed animal is to be slaugh-
tered for consumption, it should be done immedi-
ately after exposure, and all tissues should be cooked
thoroughly. Persons handling exposed animals, car-
casses, and tissues should use barrierprecautions.
Historically, federal guidelines for meat inspectors
required that any animal known to have been
exposed to rabies within 8 months be rejected for
slaughter. USDA Food and Inspection Service (FSIS)
meat inspectors should be notified if such exposures
occur in food animals before slaughter.
Rabies virus might be widely distributed in tis-
sues of infected animals (23). Tissues and products
from a rabid animal should not be used for human
or animal consumption (24). Pasteurization tempera-
tures will inactivate rabies virus; therefore, inadvert-
ently drinking pasteurized milk or eating thoroughly
cooked animal products does not constitute a rabies
exposure.
Multiple rabid animals in a herd or herbivore-to-
herbivore transmission are uncommon; therefore,
restricting the rest of the herd if a single animal has
been exposed to or infected by rabies is usually not
necessary.
c. Other Animals. Other mammals exposed to a rabid
animal should be euthanized immediately. Animals
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maintained in USDA-licensed research facilities or
accredited zoological parks should be evaluated on a
case-by-case basis.
6. Management of Animals that Bite Humans.
a. Dogs, Cats, and Ferrets. Rabies virus might be
excreted in the saliva of infected dogs, cats, and fer-
rets during illness and/or for only a few days before
illness or death (25–27). A healthy dog, cat, or ferret
that bites a person should be confined and observed
daily for 10 days (28); administration of rabies vac-
cine to the animal is not recommended during the
observation period to avoid confusing signs of rabies
with possible side effects of vaccine administration.
Any illness in the animal should be reported imme-
diately to the local health department. Such animals
should be evaluated by a veterinarian at the first sign
of illness during confinement. If signs suggestive of
rabies develop, the animal should be euthanized and
the head submitted for testing as described in Part
I.A.8. Any stray or unwanted dog, cat, or ferret that
bites a person may be euthanized immediately and
the head submitted for rabies examination.
b. Other Biting Animals. Other biting animals that
might have exposed a person to rabies should be
reported immediately to the local health department.
Management of animals other than dogs, cats, and
ferrets depends on the species, the circumstances of
the bite, the epidemiology of rabies in the area, the
biting animal’s history, current health status, and the
animal’s potential for exposure to rabies. Previous
vaccination of these animals might not preclude the
necessity for euthanasia and testing.
7. Outbreak Prevention and Control. The emergence
of new rabies virus variants or the introduction of non-
indigenous viruses poses a significant risk to humans,
domestic animals, and wildlife (29–36). A rapid and
comprehensive response includes the following
measures:
a. Characterize the virus at a national or regional reference
laboratory.
b. Identify and control the source of the introduction.
c. Enhance laboratory-based surveillance in wild and
domestic animals.
d. Increase animal rabies vaccination rates.
e. Restrict the movement of animals.
f. Evaluate the need for vector population reduction.
g. Coordinate a multiagency response.
h. Provide public and professional outreach and education.
8. Disaster Response. Animals might be displaced dur-
ing and after man-made or natural disasters and require
emergency sheltering (http://www.bt.cdc.gov/disas-
ters/petshelters.asp and http://www.avma.org/disas-
ter/default.asp) (37). Animal rabies vaccination and
exposure histories often are not available for displaced
animals. Disaster response creates situations where
animal caretakers might lack appropriate training and
preexposure vaccination. In such situations, it is criti-
cal to implement and coordinate rabies-prevention and
-control measures to reduce the risk of rabies transmis-
sion and the need for human postexposure prophylaxis.
Such measures include:
a. Coordinate relief efforts of individuals and organi-
zations with the local emergency operations center
before deployment.
b. Examine each animal at a triage site for signs of rabies.
c. Isolate animals exhibiting signs of rabies, pending
evaluation by a veterinarian.
d. Ensure that all animals have a unique identifier.
e. Administer a rabies vaccination to all dogs, cats and
ferrets unless reliable proof of vaccination exists.
f. Adopt minimum standards for animal caretakers that
include personal protective equipment, previous
rabies vaccination, and appropriate training in
animal handling (see Part I.C.).
g. Maintain documentation of animal disposition and
location (e.g., returned to owner, died or euthanized,
adopted, relocated to another shelter, and address of
new location).
h. Provide facilities to confine and observe animals
involved in exposures (see Part I.A.1.).
i. Report human exposures to appropriate public health
authorities (see Part I.B.6.).
C. Prevention and Control Methods Related to Wildlife.
The public should be warned not to handle or feed wild
mammals. Wild mammals and hybrids that bite or other-
wise expose persons, pets, or livestock should be consid-
ered for euthanasia and rabies examination. A person
bitten by any wild mammal should immediately report
the incident to a health-care provider who, in consulta-
tion with public health authorities, can evaluate the need
for postexposure prophylaxis (3).
Translocation of infected wildlife has contributed to the
spread of rabies (30–34); therefore, the translocation of
known terrestrial rabies reservoir species should be pro-
hibited. Whereas state-regulated wildlife rehabilitators and
nuisance wildlife-control operators might play a role in a
comprehensive rabies-control program, minimum stan-
dards for persons who handle wild mammals should
include rabies vaccination, appropriate training, and con-
tinuing education.
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1. Carnivores. The use of licensed oral vaccines for the
mass vaccination of free-ranging wildlife should be con-
sidered in selected situations, with the approval of the
state agency responsible for animal-rabies control (5,38).
The distribution of oral rabies vaccine should be based
on scientific assessments of the target species and fol-
lowed by timely and appropriate analysis of surveillance
data; such results should be provided to all stakehold-
ers. In addition, parenteral vaccination (trap-vaccinate-
release) of wildlife rabies reservoirs may be integrated
into coordinated oral rabies vaccination programs to
enhance their effectiveness. Continuous and persistent
programs for trapping or poisoning wildlife are not
effective in reducing wildlife rabies reservoirs on a state-
wide basis. However, limited population control in high-
contact areas (e.g., picnic grounds, camps, and
suburban areas) might be indicated for the removal
of selected high-risk species of wildlife (5). State ag-
riculture, public health, and wildlife agencies should
be consulted for planning, coordination, and evalua-
tion of vaccination or population-reduction programs.
2. Bats. Indigenous rabid bats have been reported from
every state except Hawaii and have caused rabies in at
least 40 humans in the United States (39–46). Bats
should be excluded from houses, public buildings, and
adjacent structures to prevent direct association with
humans (47,48). Such structures should then be made
bat-proof by sealing entrances used by bats. Control-
ling rabies in bats through programs designed to
reduce bat populations is neither feasible nor desirable.
Part II: Recommendations
for Parenteral Rabies
Vaccination Procedures
A. Vaccine Administration. All animal rabies vaccines
should be restricted to use by or under the direct super-
vision of a veterinarian (49), except as recommended
in Part I.B.1. All vaccines must be administered in
accordance with the specifications of the product label
or package insert.
B. Vaccine Selection. Part III lists all vaccines licensed by
USDA and marketed in the United States at the time
of publication. New vaccine approvals or changes in
label specifications made subsequent to publication
should be considered as part of this list. Any of the listed
vaccines can be used for revaccination, even if the
product is not the same as previously administered.
Vaccines used in state and local rabies-control pro-
grams should have at least a 3-year duration of im-
munity. This constitutes the most effective method
of increasing the proportion of immunized dogs and
cats in any population (50). No laboratory or epide-
miologic data exist to support the annual or biennial
administration of 3- or 4-year vaccines following the
initial series.
C. Adverse Events. Currently, no epidemiologic asso-
ciation exists between a particular licensed vaccine
product and adverse events (51,52). Adverse events,
including rabies in a previously vaccinated animal,
should be reported to the vaccine manufacturer and to
USDA, Animal and Plant Health Inspection Service,
Center for Veterinary Biologics (Internet: http://www.
aphis.usda.gov/animal_health/vet_biologics/vb_
adverse_event.shtml; telephone: 800-752-6255; or
e-mail: cvb@usda.gov).
D. Wildlife and Hybrid Animal Vaccination. The safety
and efficacy of parenteral rabies vaccination of wildlife
and hybrids have not been established, and no rabies
vaccines are licensed for these animals. Parenteral vac-
cination (trap-vaccinate-release) of wildlife rabies res-
ervoirs can be integrated into coordinated oral rabies
vaccination programs as described in Part I.C.1. to
enhance their effectiveness. Zoos or research institutions
may establish vaccination programs to attempt to pro-
tect valuable animals, but these should not replace
appropriate public health activities that protect humans
(see Part I.B.1.c.2) (9).
E. Accidental Human Exposure to Vaccine. Human
exposure to parenteral animal rabies vaccines listed in
Part III does not constitute a risk for rabies virus infec-
tion. Human exposure to vaccinia-vectored oral rabies
vaccines should be reported to state health officials (53).
F. Rabies Certificate. All agencies and veterinarians
should use NASPHV Form 51 (revised 2007), Rabies
Vaccination Certificate, or an equivalent. This form can
be obtained from vaccine manufacturers, NASPHV
(http://www.nasphv.org/Documents/RabiesVacCert.
pdf), or CDC (http://www.cdc.gov/rabies). The form must
be completed in full and signed by the administering or
supervising veterinarian. Computer-generated forms
containing the same information are also acceptable.
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Part III: Rabies vaccines licensed and marketed in the United States, 2008
License For Dosage Age at primary Booster Route of
Product name Produced by no. Marketed by use in (mL) vaccination* recommended inoculation
A) MONOVALENT (inactivated)
RABVAC 1 Fort Dodge 112 Fort Dodge Dogs 1 3 mos† Annually IM§ or SC¶
  Animal Health  Animal Health Cats 1 3 mos Annually IM or SC
RABVAC 3 Fort Dodge 112 Fort Dodge Dogs 1 3 mos 1 year later and triennially IM or SC
  Animal Health  Animal Health Cats 1 3 mos 1 year later and triennially IM or SC
   Horses 2 3 mos Annually IM
RABVAC 3 TF Fort Dodge 112 Fort Dodge Dogs 1 3 mos 1 year later and triennially IM or SC
  Animal Health  Animal Health Cats 1 3 mos 1 year later and triennially IM or SC
   Horses 2 3 mos Annually IM
DEFENSOR 1 Pfizer, Inc. 189 Pfizer, Inc. Dogs 1 3 mos Annually IM or SC
  Cats 1 3 mos Annually SC
DEFENSOR 3 Pfizer, Inc. 189 Pfizer, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
  Cats 1 3 mos 1 year later and triennially SC
   Sheep 2 3 mos Annually IM
   Cattle 2 3 mos Annually IM
RABDOMUN Pfizer, Inc. 189 Schering-Plough Dogs 1 3 mos 1 year later and triennially IM or SC
  Cats 1 3 mos 1 year later and triennially SC
   Sheep 2 3 mos Annually IM
   Cattle 2 3 mos Annually IM
RABDOMUN 1 Pfizer, Inc. 189 Schering-Plough Dogs 1 3 mos Annually IM or SC
  Cats 1 3 mos Annually SC
CONTINUUM RABIES Intervet, Inc. 286 Intervet, Inc. Dogs 1 3 mos 1 year later and triennially SC
  Cats 1 3 mos 1 year later and quadrennially SC
PRORAB-1 Intervet, Inc. 286 Intervet, Inc. Dogs 1 3 mos Annually IM or SC
  Cats 1 3 mos Annually IM or SC
   Sheep 2 3 mos Annually IM
IMRAB 1 Merial, Inc. 298 Merial, Inc. Dogs 1 3 mos Annually SC
  Cats 1 3 mos Annually SC
IMRAB 1 TF Merial, Inc. 298 Merial, Inc. Dogs 1 3 mos Annually SC
  Cats 1 3 mos Annually SC
IMRAB 3 Merial, Inc. 298 Merial, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
  Cats 1 3 mos 1 year later and triennially IM or SC
   Sheep 2 3 mos 1 year later and triennially IM or SC
   Cattle 2 3 mos Annually IM or SC
   Horses 2 3 mos Annually IM or SC
   Ferrets 1 3 mos Annually SC
IMRAB 3 TF Merial, Inc. 298 Merial, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
  Cats 1 3 mos 1 year later and triennially IM or SC
   Ferrets 1 3 mos Annually SC
IMRAB Large Animal Merial, Inc. 298 Merial, Inc. Cattle 2 3 mos Annually IM or SC
 Horses 2 3 mos Annually IM or SC
   Sheep 2 3 mos 1 year later and triennially IM or SC
B) MONOVALENT (Rabies glycoprotein, live canary pox vector)
PUREVAX Feline Rabies Merial, Inc. 298 Merial, Inc. Cats 1 8 wks Annually SC
C) COMBINATION (Inactivated rabies)
CONTINUUM DAP-R Intervet, Inc. 286 Intervet, Inc. Dogs 1 3 mos 1 year later and triennially SC
CONTINUUM Feline HCP-R Intervet, Inc. 286 Intervet, Inc. Cats 1 3 mos 1 year later and quadrennially** SC
Equine POTOMAVAC + IMRAB Merial, Inc. 298 Merial, Inc. Horses 1 3 mos Annually IM
D) COMBINATION (Rabies glycoprotein, live canary pox vector)
PUREVAX Feline 3/Rabies Merial, Inc. 298 Merial, Inc. Cats 1 8 wks Annually SC
PUREVAX Feline 4/Rabies Merial, Inc. 298 Merial, Inc. Cats 1 8 wks Annually SC
E) ORAL (Rabies glycoprotein, live vaccinia vector) — RESTRICTED TO USE IN STATE AND FEDERAL RABIES-CONTROL PROGRAMS
RABORAL V-RG Merial, Inc. 298 Merial, Inc. Coyotes N/A†† N/A As determined by local Oral
  Raccoons     authorities  
* Minimum age (or older) and revaccinated 1 year later.
† One month = 28 days.
§ Intramuscularly.
¶ Subcutaneously.
** Nonrabies fractions have a 3-year duration (see label).
†† Not applicable.
Rabies vaccine manufacturer contact information
Manufacturer Phone number Internet address
Fort Dodge Animal Health 800-533-8536 http://www.wyeth.com/divisions/fort_dodge.asp
Intervet, Inc. 800-835-0541 http://www.intervetusa.com
Merial, Inc. 888-637-4251 http://us.merial.com
Pfizer, Inc. 800-366-5288 http://www.pfizerah.com
Schering-Plough Animal Health 800-521-5767 http://www.spah.com/usa
Note: ADVERSE EVENTS: Adverse events should be reported to the vaccine manufacturer and to U.S. Department of Agriculture, Animal and Plant Health Inspection Service,
Center for Veterinary Biologics (Internet: http://www.aphis.usda.gov/animal_health/vet_biologics/vb_adverse_event.shtml); telephone: 800-752-6255; or e-mail: cvb@usda.gov).
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